| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $8.9B | $9.2B | $10.9B | $12.5B | $8.7B | $1.5B | $1.6B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $1.6B | $2.9B | $3.9B | $1.5B | $-0.6B | $-0.0B |
| Net Income | $1.2B | $1.1B | $2.1B | $3.6B | $1.4B | $-0.6B | $-0.0B |
| EPS (Basic) | $4.83 | $4.25 | $8.02 | $14.34 | $5.44 | $-2.36 | — |
| EPS (Diluted) | $4.78 | $4.21 | $7.90 | $14.08 | $5.32 | $-2.36 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $20.4B | $19.3B | $20.0B | $15.1B | $14.1B | $14.5B | $21.5B |
| Current Assets | $1.5B | $1.4B | $1.7B | $1.7B | $1.6B | $1.2B | $1.9B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B | $0.0B | $0.2B |
| Total Liabilities | $9.2B | $8.9B | $9.6B | $7.4B | $9.0B | $10.6B | $11.6B |
| Current Liabilities | $2.8B | $2.7B | $2.8B | $2.8B | $2.7B | $2.4B | $2.4B |
| Stockholders' Equity | $11.2B | $10.3B | $10.4B | $7.7B | $5.1B | $3.8B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $3.7B | $4.2B | $3.9B | $3.1B | $1.9B | $2.9B |
| Investing Cash Flow | $-2.9B | $-2.5B | $-5.5B | $-1.8B | $-0.5B | $-1.9B | $-2.6B |
| Capital Expenditures | $2.1B | $2.3B | $2.7B | $1.8B | $1.5B | $1.7B | $2.6B |
| Financing Cash Flow | $-0.8B | $-1.2B | $1.4B | $-2.3B | $-2.4B | $-0.2B | $-1.2B |